Genocea Biosciences reported $37.83M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Baxter International BAX:US $ 8770M 276M
Bluebird Bio BLUE:US $ 870.53M 114.03M
Cytokinetics CYTK:US $ 249.02M 232.53M
Cytori Therapeutics CYTX:US $ 14.76M 2.81M
Genocea Biosciences GNCA:US $ 37.83M 33.77M
Glaxosmithkline GSK:US $ 15426M 49M
Infinity Pharmaceuticals INFI:US $ 32.14M 9.4M
Mirati Therapeutics MRTX:US $ 1084.03M 44.9M
Moderna Inc MRNA:US 10.12B 3.42B
Novavax NVAX:US $ 461.34M 284.23M
Prothena PRTA:US $ 490.47M 202.26M